Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC1A3 | P43003 | 1/20 | 0.48 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.48 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.48 |
| ▸ | TACR1 | P25103 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 2/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.45 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.43 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.42 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.42 |
| ▸ | REN | P00797 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6519798 | 0.87 | SLC1A3 (0.50) | SLC1A3SLC1A2SLC1A1TACR1RAB9A | |
| SCHEMBL20182728 | 0.84 | TACR1 (0.55) | SLC1A3SLC1A2SLC1A1TACR1CYP1A2 | |
| SCHEMBL28936084 | 0.83 | CYP1A2 (0.54) | SLC1A3SLC1A2SLC1A1TACR1RAB9A | |
| SCHEMBL15020010 | 0.82 | THRB (0.46) | SLC1A3SLC1A2SLC1A1TACR1RAB9A | |
| SCHEMBL15020200 | 0.82 | THRB (0.46) | SLC1A3SLC1A2SLC1A1TACR1RAB9A | |
| SCHEMBL26936005 | 0.82 | THRB (0.46) | SLC1A3SLC1A2SLC1A1TACR1RAB9A | |
| SCHEMBL6443296 | 0.81 | SLC1A3 (0.51) | SLC1A3SLC1A2SLC1A1TACR1RAB9A | |
| SCHEMBL6443298 | 0.81 | SLC1A3 (0.55) | SLC1A3SLC1A2SLC1A1TACR1RAB9A | |
| SCHEMBL11145716 | 0.80 | TACR1 (0.43) | SLC1A3SLC1A2SLC1A1TACR1RAB9A | |
| SCHEMBL15020074 | 0.80 | TACR1 (0.43) | SLC1A3SLC1A2SLC1A1TACR1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050269563-A1 | Fullerodendrimer-comprising film | ECODEVICE LABORATORY CO., LTD. (JP) | 2005-12-08 | — | — | US | disclosed |
| US-20040175568-A1 | Can be applied to organic semiconductor devices utilizing the optophysicochemical characteristics of fullerene, and in particular, to solar panel materials, organic EL materials, photorefractive polymers, electrophotographic light-sensitive materials, film materials having environmental cleansing actions | ECODEVICE LABORATORY CO., LTD. (JP) | 2004-09-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050269563-A1 | Fullerodendrimer-comprising film | TOMM70, SCO2, S100A10 | SLC1A3 2516/4885SLC1A2 2535/4885SLC1A1 3143/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.